Compound information
- Natural Products
- ZC620932
- Molecular Formula
- C15H22N2O4
- Molecular Weight
- 294.157957184 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-(methoxymethylcarbamoyl)butyl]carbamate
- InChI
- InChI=1S/C15H22N2O4/c1-3-7-13(14(18)16-11-20-2)17-15(19)21-10-12-8-5-4-6-9-12/h4-6,8-9,13H,3,7,10-11H2,1-2H3,(H,16,18)(H,17,19)/t13-/m0/s1
- InChI Key
- PZCDOTYJJIBHHJ-ZDUSSCGKSA-N
- SMILES
- CCC[C@H](NC(=O)OCc1ccccc1)C(=O)NCOC
- Source
- ZINC000398635841
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 76.66 Å2 | LogP | 1.807 |
LogS | -2.326 | LogD | 2.543 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.045 | Pgp substrate | 0.013 |
HIA | 0.964 | F20 % | 0.994 |
F30 % | 0.034 | Caco-2 | -4.641 |
MDCK | -4.681 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.828 | PPB | 70.741 |
VD | 0.871 | Fu | 0.721 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.023 | CYP1A2 substrate | 0.779 |
CYP2A6 substrate | 0.628 | CYP2B6 substrate | 0.667 |
CYP2C19 inhibitor | 0.334 | CYP2C19 substrate | 0.917 |
CYP2C8 substrate | 0.781 | CYP2C9 inhibitor | 0.318 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.005 |
CYP2D6 substrate | 0.972 | CYP2E1 substrate | 0.471 |
CYP3A4 inhibitor | 0.084 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.761 | CL | 6.906 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.006 | Hepatotoxicity | 0.565 |
Mutagenicity | 0.061 | Rat Oral Acute Toxicity | 0.014 |
FDAMDD | 0.123 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.029 | Eye Corrosion | 0.005 |
Eye Irritation | 0.038 | Respiratory Toxicity | 0.006 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.154 | IGC50 | 2.488 |
LC50FM | 3.425 | LC50DM | 5.077 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.075 | NR-AR-LBD | 0.194 |
NR-AhR | 0.002 | NR-Aromatase | 0.031 |
NR-ER | 0.189 | NR-ER-LBD | 0.318 |
NR-PPAR-gamma | 0.206 | SR-ARE | 0.045 |
SR-ATAD5 | 0.385 | SR-HSE | 0.133 |
SR-MMP | 0.027 | SR-p53 | 0.017 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.